text:
MILWAUKEE--- Marlon Byrd isn't trying to convince you, change your mind, or even be accepted.
He knows there are people out there convinced he's cheating, that somehow, someway, he has found a way to circumvent the system.
He is OK with that.
"I'm always going to get questions asked of me,'' Byrd told USA TODAY Sports on Tuesday, "and I don't mind that. Really, I don't. I can't. I hear the questions:
"What is he doing?
"Is he taking something?
"Is he cheating?''
Byrd says this all this without anger in his voice. There is no level of frustration. It will take time.
"I understand why people are skeptical,'' says Byrd, a popular player among his peers. "I just have to play hard and hopefully people will believe in me.''
Certainly, he knows why those in and around the game could find it incredulous that he's having this glorious season - a career-high 22 homers, 77 RBI, a trade from the languishing New York Mets to the contending Pittsburgh Pirates - without the benefit of performance-enhancing drugs.
Yes, he received a 50-game suspension in June 2012 for taking performance-enhancing drugs, and never returned to the big leagues.
Yes, he is close friends with Victor Conte, the founder of BALCO, and has taken Conte's legal supplements since 2008.
Yes, his agents are Sam and Seth Levinson of ACES, who are under investigation by Major League Baseball after a former employee, Juan Nunez, was directly involved with more than 10 players who were linked to the Biogenesis scandal.
Oh, and he's having the greatest season of his 12-year career, a year that likely will culminate with his first playoff appearance.
And he's doing all this at of 36 - seven months after playing in Mexico.
"You put all those factors in,'' Byrd says, "It's like, 'OK, how is he doing it? You're not supposed to be getting better with age?'"
He welcomes all inquiries.
The National League's overwhelming favorite for Comeback Player of the Year already has been subjected to four drug tests this year, and now that the Pirates are closing in on their first postseason berth in 21 years, there will be more coming.
BUC THE TREND?: Pirates feel time may be now
"When you're clean, drug testing shouldn't bother you,'' Byrd says. "They can test me a 100 times. To urinate in a cup takes 10 minutes out of your day. It shouldn't bother you.''
The scrutiny was actually worse back in 2009, when Byrd played for the Texas Rangers. He revealed that he was a regular customer of Conte's taking supplements from his SNAC company in Burlingame, Calif.
The next thing Byrd knew, he was taking 11 drug tests that season alone.
"That goes with the territory,'' Conte told USA TODAY Sports on Tuesday. "If you're clean, you don't care how often they come. There's no ducking anything with Marlon.
"If you have something to hide, you're certainly not going to let it be publicly known that you are associating with me, because you put a target on your back.''
Says Byrd: "The easiest thing for me to have done is cut ties with Victor. To cut ties with Sam and Seth. But you only do that when you're guilty of something. You don't get rid of family. We all stuck together.''
Byrd insists that he has never taken steroids, human growth hormone or testosterone.
He did use Tamoxifen, most commonly used to treat breast cancer, and tested positive last year, ending his season. For athletes, the drug counteracts the side effect of enlarged breasts often caused by using steroids, but Byrd said then he took it for a condition called gynecomastia, which was caused when he lost 35 pounds during the winter of 2011.
"I have a condition, and I was taking that,'' Byrd says, "It was just me not doing my due diligence. It was me being stupid.''
He was released by the Red Sox two weeks before his positive test; though he was eligible forreinstatement Aug. 21, no one was interested.
He went home to Calabasas, Calif. and told his agents to find a team in Mexico. He left Sept. 26 for spring training in Tijuana, and spent four months playing for Culiacan .
He changed his hitting mechanics, even his grip to create extension. He began driving the ball to all fields.
And still, no calls.
"It was like, 'Oh, he must be done. He's finished,' '' Byrd says. "I refused to believe it. I knew I could still play.''
Finally, in early February, the Mets invited Byrd to their spring-training camp. They would pay him $700,000 - $200,000 more than the minimum - and only if he made the opening-day roster. Byrd accepted, knowing it likely would be his final shot.
"You only need one team to believe in you,'' Byrd said, "and the Mets were that team. I'll be grateful to them for the rest of my career.''
And now, he has found redemption, perhaps providing a path for the 14 players suspended for using performance-enhancing drugs in the Biogenesis investigation.
It won't be easy, Byrd knows. Brewers outfielder Ryan Braun, in particular, is going to be a target. He's got a huge contract. He's a former MVP. And he let down those, particularly his peers, who believed in him.
"He'll hear the boos," says Byrd. "The steroid chants. Maybe even out at dinner, on the road, people saying stuff. That's where it will be difficult.
"It will take a year, maybe two or three years, it will be gone. He's already done his apology. How much more can you punch a guy?''
Byrd's proof that even after absorbing a body blow, it's still possible to stand tall.


text:
GMX Chip Red 50cc Dirt Bike
|Physical Kill Switch
|The physical kill switch is a switch you flick if you want the motor to cut out, it is generally located on the left side of the handle bar.
|Maximum Speed
|50km/h (depending on terrain and load)
|Seat Height
|63 cm
|Performance Steel Muffler ( whole electroplate)
|Final Drive
|Black KMC # 420 Chain
|Front Fork
|500 mm upright
|Front / rear 10 - 10 steel electroplate wheel
|Products are up to 90% assembled. Minor assembly is required and in the interested of safety it is recommended that you have the quad bike assembled by a qualified, skilled small engine mechanic.
|Engine Model
|Normal brand engine
|Engine Type
|4 Stroke - Single Cylinder
|Starting Mode
|Electric Start + Kick Start
|19 mm JINKE
|Cooling System
|Air Cooled
|50cc Semi Automatic-N1234
|Shock Absorber
|Normal rear spring
|The cap of Fuel tank
|Front Brake
|Drum Brake
|Rear Brake
|Drum Brake
|Maximum Load
|Rider Capacity
|1 Person
|Product Size
|140cm x 74cm x 86cm (LxWxH )
|Important Safety & Product Information
|Always wear a helmet, product clothing and gear such as goggles, long sleeves, long pants, boots and gloves/hand protection when riding these products. For motorised products a motorbike standard helmet needs to be worn. Never let children ride dirt bikes that are meant for adults, even as passengers. Do not carry any passengers on dirt bikes that are meant for one person. Dirt bikes are not all-terrain vehicles so they cannot go safely on all types of terrain. Avoid riding on rough terrain or steep slopes. Ride on familiar tracks and beware of obstacles. Never ride under the influence of alcohol/drugs. Ensure children are supervised at all times near any dirt bike activity. Always carry a mobile phone or radio device so you can contact help in case of an emergency. Always adhere to the maximum load of the product. Minor assembly is required In the interest of safety it is recommended that you have this bike assembled by a skilled bike mechanic. You may need to provide proof of being assembled by a skilled mechanic, if not a report from a small engine mechanic advising the issues to process you warranty claims. Labour is not covered under warranty. Warranty is a parts replacement warranty and does not cover labour costs. Defective parts may need to be sent back to us for inspection. Before using the product, check that all nuts, wiring and bolts are tightened as they can become loose during shipping. For the first tank, run in the engine, please do not over-rev the engine for the first 1-3 months as the engine is new and should be treated as such. This item is intended for off road use only.
|Product Weight
|Gross Weight
|Packaging Dimensions
|135 * 36 * 71 cm
Our goods come with guarantees that cannot be excluded under the Australian Consumer Law. You are entitled to a replacement or refund for a major failure and compensation for any other reasonably foreseeable loss or damage. You are also entitled to have the goods repaired or replaced if the goods fail to be of acceptable quality and the failure does not amount to a major failure.
The manufacturer warrants this product to be free of manufacturing defects for a period of 12 months from date of purchase. This Limited Warranty does not cover normal wear and tear( exlcusions apply) or any damage, failure or loss caused by improper assembly, maintenance, or storage or use of the GMX product. Some parts will have a limited warranty period, please see below. This warranty is a part replacement warranty.
3 Month Parts Replacement Parts
Electrical compenonts, supsenison, drive train and brakes/fittings.
30 Days Parts Replacement Parts
Bearings, tires, tubes, cables, clutches, brake pads, seats
Minor assembly is required and in the interest of safety and warranty it is recommended that you have this product assembled by a qualified, skilled small engine mechanic.
You may need to provide proof of being assembled by a skilled mechanic if not a report from a small engine mechanic advising of the issues to process your warranty claims.
The warranty is a parts replacement warranty and labor is not included, defective parts may need to be sent back for inspection.
This Limited Warranty will be void if the product is ever;
- Used in a manner other than for recreation or transportation
- Modified in anyway
- Rented or commercial use.
The manufacturer is not liable for incidental or consequential loss or damage due directly or indirectly to the use of this product.
Always adhere to the maximum load of the product, over loading the product will void the warranty.
How a claim is made
When making a claim, you will need to provide proof of purchase, condition photos of the item. This information is required to be submitted via the support center and communication is made through the support center. When the claim is created, the customer will receive the claim number and the customer support team should reply within 48 hours.
What payment types are accepted?
VISA, MasterCard, PayPal and GoEasy Gift cards.
Go Easy Bank Transfer Details
Commonwealth Bank
Account name: Go Easy Online
Account Number: 102 44 175
*Please ensure when making payment that the order number is used as the payment reference,
if this is not done delays cam occur in applying payment to your order.
How do I know my card details are secure?
We use Secure Socket Layer (SSL) and payment gateway for all orders placed to ensure the security of your personal card details.
Our secure web pages can be identified by their URL: that begins with 'https://', while standard pages begin with 'http://'.
A padlock or key will also be visible in the bottom right of your web browser.
Go Easy Australia Fraud Protection Security
At Go Easy Australia, we have a fraud protection security procedure in place which may occur to any order placed via our website/s.
Having this in place ensures peace of mind and the highest level of security protection for all our customers who shop with GMX Motorbikes.
A notification email will be sent to you, if your order as become part of this fraud protection security procedure.
Please follow the instructions on the email and call us to get your order processed.
Can I still order online if I don't have a credit card?
Yes, you can use a debit card (VISA or MasterCard) or open a PayPal account or pay via Bank Transfer
How do I get a PayPal account?
Visit the PayPal website www.paypal.com.au and sign-up for an account.

subset: commoncrawl


text:
Posted 8 years ago
(2 items)
This cup (I think you would call it cut glass) has been handed down in my family. It has a note with it that was written by my grandmother (Irma E Turner Laws) that says, "This was made in London in my father's grandmother's glass factory. This blue glass is very rare." Irma's father was James Edgar Turner (1865-1942) and his parents were James E Turner (1825-? born in England) and Mary Bebee (1833-?) also born in England. Can anyone tell me about this? Thanks so much. Sandy White


text:
I do not like this exploit use of the Egyptian late officer Yasser Fareg in our regime national media. With all my respect to the late major and his family I feel that he is being used in a very dirty media war.
The regime made a huge military funeral for the late major in his home town at Kafr El-Sheikh I do not recall that any of more officers and soldiers who were killed by the IDF fires on the borders in the last two years had a funeral like it !!
I do not know if it is because of the rank or what but those officers and soldiers that were killed were technically buried secretly without any funeral !!
Late Yasser is Egyptian just like them and they were doing their job just like him.
The name of late Yasser will be called on a street and a school in Kafr El-Sheikh , now I wonder if he were killed by Israeli gunfire , would he receive the honor and respect he deserves ??
The NDP turned his funeral a protest against Hamas turning the people against them in the most worse way ever with banners , from where they got the time and money needed to make those banners !!??
If we are speaking about paying respect to those men who paid their souls on the borders whether by the hands of Israel or Hamas then all of them must be treated in the same way.
I think late Fareg will want this in his place right now.
By the way is it the fashion nowadays for the Al Azhar Clerics and Sheikhs to say who is a martyr and who is not.
With my all respect to Al Azhar Clerics front ,this statement they issued today saying that Fareg is not and indirectly they said that he is in hell !!With all my respect to their knowledge , we do not know exactly what happened there in this bloody night and Muslims do not jump on conclusion in this way.


text:
Implementing methadone maintenance treatment in prisons in Malaysia
Jeffrey A Wickersham a, Ruthanne Marcus a, Adeeba Kamarulzaman b, Muhammad Muhsin Zahari b & Frederick L Altice a b
a. Yale University School of Medicine, Department of Medicine, Infectious Diseases Section, AIDS Program, 135 College Street (Suite 323), New Haven, CT 06510 2283, United States of America (USA).
b. University of Malaya, Centre of Excellence for Research in AIDS, Kuala Lumpur, Malaysia.
Correspondence to Frederick L Altice (e-mail: firstname.lastname@example.com).
(Submitted: 20 June 2012 – Revised version received: 15 October 2012 – Accepted: 13 November 2012.)
Bulletin of the World Health Organization 2013;91:124-129. doi: 10.2471/BLT.12.109132
In 2005, Malaysia, a middle-income country, was in the throes of one of south-eastern Asia's most explosive epidemics of human immunodeficiency virus (HIV) infection. The epidemic was largely concentrated among people who inject drugs, especially opioids, who comprised more than 1.3% of the population between the ages of 15 and 64 years. Nearly half of all new HIV infections in Malaysia occur among people who inject opioids. In light of this and of the lack of progress towards achieving the Millennium Development Goal of reducing the rate of HIV infection, Malaysia introduced needle and syringe exchange programmes and methadone maintenance treatment (MMT) programmes in 2005 as part of a harm reduction strategy targeting people who inject opioids.1
MMT, an evidence-based therapy for opioid dependence, has been associated with numerous benefits. In addition to reducing opioid use, it lowers risky practices, HIV transmission and criminal behaviour.2 Within prisons, MMT has been shown to dramatically reduce deaths from drug overdose,3 which is the leading direct cause of death over the two weeks that immediately follow release from prison.4 Despite this evidence of their benefits in the community5,6 and in criminal justice settings,7–11 MMT programmes have expanded very slowly and continue to have low coverage. In this report we describe how Malaysia initiated MMT within two prisons and examine the obstacles that hampered implementation and retention in care after prisoners' release. Such lessons may be useful in other settings where plans to establish harm reduction programmes for HIV-infected individuals who inject opioids are under way.
Setting and approach
In Malaysia, which has a population of 28.3 million, an estimated 205 000 people inject illicit drugs and 78 419 people have HIV infection. The country has approximately 43 000 prisoners and an incarceration rate of 174 per 100 000. Testing of prisoners for HIV is mandatory; about 6% of them test positive.12
Malaysia's initial experience with the implementation of needle and syringe exchange programmes and MMT programmes has been described elsewhere.13,14 The MMT programme was rolled out in three phases. In Phase I, MMT was introduced in specialty clinics for people with drug dependence, and in Phase II it was expanded to primary care settings. In 2006 prison officials including the Director-General of the Malaysian Prisons Department, made a site visit to Iranian prisons to learn more about the use of MMT in an Islamic context. By 2007, Malaysia's Prisons Department had decided to pilot an MMT programme in an attempt to reduce HIV infection and reincarceration rates. In partnership with the Ministry of Health and leading national and international experts, the department developed standard operating procedures for deployment of MMT in prisons by adapting the operating procedures in place for community-based MMT. The standard operating procedures for prisons called for initiation of MMT from 3 to 6 months before a prisoner's release, slow escalation of the methadone dose because of the danger of intolerance to opioids, and the establishment of mechanisms for referring patients to community-based MMT after their release from prison. In this paper we present the data from Phase III, which consisted of the rollout of methadone in the two prisons in Malaysia with the highest prevalence of HIV infection among their inmates.
The first pilot MMT study began in Pengkalan Chepa prison, in the state of Kelantan, in 2008. Later the same year the programme was expanded to Kajang prison, in the state of Selangor. Participants in both pilot programmes were observed for 12 months. We first used MMT in prisoners who were HIV-infected to facilitate their medical care after their release. Because prison health programmes in Malaysia were at an early stage of development, the United Nations Office on Drugs and Crime funded intensive training for prison clinicians and correctional staff, as well as for community-based MMT programme providers. Officials from the Prisons Department and physicians prescribing methadone in the prison and community were selected for this training.
For the analysis we divided the factors that stood as deterrents and facilitators to the implementation of these prison-based MMT programmes into three categories: patient-, staff- and institution-level factors. We conducted one-on-one interviews with clients, both in the prison before their release and regularly after their release, to assess their experiences with the programme. Focus groups of 8 prisoners released from Pengkalan Chepa and 11 released from Kajang prison who had remained on MMT were conducted to gather more detailed information about their experiences with methadone treatment. We also spoke with prison physicians prescribing methadone about their experiences throughout the course of the pilot programme.
Patient-level factors
Under the former standard operating procedures, the daily starting dose of 5 mg of methadone was escalated by 5 mg every 3 to 4 days. In Pengkalan Chepa we found that this escalation rate was too rapid; many patients experienced severe nausea, vomiting and somnolence. For this reason, in Kajang we escalated the dose by 5 mg every 7 days rather than every 5, and no patients experienced these symptoms. We had to extend treatment duration to more than 3 months to allow sufficient time to escalate the daily dose of methadone to more than 80 mg before a prisoner's release. Ongoing training of physicians and patients was required to ensure that escalation of the dose of methadone was individualized in accordance with each patient's symptoms. We also observed high rates of abstinence syndrome and in several cases had to increase the dose of methadone. This occurred most often in patients who were receiving anti-tuberculosis agents or antiretroviral therapy (ART), both of which can markedly reduce methadone levels.2 About one fourth of the MMT programme participants in both prisons had to be treated for tuberculosis. This was a surprisingly high percentage, although the incidence of tuberculosis is known to be high among HIV-infected prisoners. Patients who were released from prison on a daily methadone dose of more than 80 mg had better treatment retention rates 12 months after release than those who were released on a lower dose (Table 1).15 This finding has also been observed in community-based MMT programmes.16
Table 1. Characteristics of HIV-infected participants in methadone maintenance treatment (MMT) programmes and outcomes observed before and after their release from prison, Kajang and Pengkalan Chepa prisons (Selangor and Kelantan states, respectively), Malaysia, 2008–2009
html, 10kb
Most prisoners were unwilling to have their HIV status disclosed to their families but requested that their families be educated about the benefits of MMT. Many prisoners were poorly connected with their families because of their opioid dependence and believed that being "treated" would help them to restore their broken family ties. Prisoners' relatives seemed to appreciate being taught about MMT, yet some of them quarantined former prisoners within the household and treated them with distrust. Finally, despite knowing that MMT has long-term benefits, many patients expected to have all opioids eventually discontinued.
Staff-level factors
At first the primary care physicians in the prison were reluctant to initiate MMT because they felt uncomfortable treating opioid dependence. This was resolved through one-on-one supervision and training, which covered the rationale behind MMT, appropriate dosing of the drug, its adverse side-effects, its pharmacokinetic interactions, and the logistical issues involved in providing for patients' transitional care. Physicians and patients both wanted to keep doses "low" because they feared the "addictive" effects of MMT. A daily dose of more than 80 mg was established to reduce under-prescribing. In the planning stage there were concerns about possible diversion and overdose; these concerns did not materialize after the standard operating procedures pertaining to clinical care were developed. In Pengkalan Chepa, patients on MMT were initially quarantined while their methadone dose was escalated, but since no adverse effects were observed, this practice was later discontinued. Occasionally, inmates and prison staff engaged in anti-methadone rhetoric that discouraged patients on MMT from continuing their therapy. To overcome this problem and reinforce treatment goals, separate educational sessions for inmates and staff were conducted periodically, generally 3 to 6 months after initiation of the pilot programme.
Educational sessions on the benefits of MMT had to be held repeatedly because of the turnover in prison staff. The highest-ranking prison officials supported the MMT programme, but the high turnover in lower-ranking staff threatened to undermine it. To allay their doubts and address their concerns, we reassured officials that the pilot studies were being monitored and provided programmatic feedback and interactive discussions quarterly. Although all prison officials should receive standardized training, continuing training and monitoring were instructive and helpful in avoiding disruption of the MMT programme as a result of frequent changes in staff.
Institutional-level factors
One critical facilitator and four institutional deterrents were observed during the implementation of MMT programmes. Central to success was the support of the Director-General of the Prisons Department, who was involved from the inception of the programme. Four institutional deterrents, however, also acted as hindrances. First, local police could impose corrective measures without notifying the Prisons Department. For example, they could order prisoners to be relocated to a remote area after their release. Last minute coordination was required to ensure that community-based prisoners had access to a site offering MMT. As a result, relocated patients were less likely to be retained in treatment. Second, the exact date of a prisoner's release was not always known in advance. All patients on MMT were therefore instructed to inform prison staff of their treatment so that their release from prison could be delayed until after their next dose of MMT and the prison physician had had a chance to have their MMT records transferred to a community MMT site. Third, "lock-downs" – periods when staff put a stop to all movement within the prison for security reasons – threatened to impede prisoners' access to MMT, and physicians responded in anticipation of such events by distributing methadone directly to their cells. Finally, some community-based MMT programmes reduced patients' methadone dose after release from prison because they mistakenly considered it too high. Hence, the staff of community-based MMT sites must be made aware of the importance of a high enough maintenance dose of methadone and of the need to escalate the dose in patients released from prison receiving 80 mg or less a day.
Post-release continuity of care
Ensuring continuity of care after release from prison remains difficult because patient supervision lies outside the prison system. Since most MMT programmes are located in urban settings, individuals returning to rural settings had to either forfeit MMT or agree to travel to a community MMT site. A travel distance of more than 25 km was associated with lower retention in treatment. As community-based MMT programmes expand to rural areas, so too can prison-based MMT programmes. Linking patients to MMT upon release was not difficult when the pre-release paperwork was completed in advance and properly transmitted to the community MMT site, especially when accompanied by a phone call to ensure receipt.
Despite education of family members about MMT, reuniting patients with their families often proved problematic; many patients were met with hostility by their relatives. Innovative, culturally-specific educational sessions should be provided before and after release to reduce family conflict around MMT. Re-integration with the family is the most critical aspect of re-entry into society. For patients lacking family support, however, transitional services that provided assistance with reintegration into society (e.g. employment, housing, care for HIV infection, etc.) were just as important in ensuring their retention in MMT.
Finally, retention in care was hindered by arrest and harassment of MMT clients by police near MMT sites. Some patients reported they avoided coming to receive their methadone on days when police were waiting outside the programme, or, in some cases, that they discontinued it completely to avoid being detained or bribed. As a result, police were subsequently educated about the benefits of MMT. On the whole, however, prisoners did not report lack of continuity of MMT as their main problem upon re-entering society. Fig. 1 provides a list of the problems they considered most important. Staying off illicit drugs was not highest among them.12
Fig. 1. Most common difficulties (%) reported by participants in methadone maintenance treatment (MMT) programmes, Kajang and Pengkalan Chepa prisons (Selangor and Kelantan states, respectively), Malaysia
Prison-based MMT holds considerable promise for reducing HIV infection rates among prison inmates and the general population (Box 1). Implementing MMT in prisons is not easy, although the difficulties are not insurmountable. Other evidence-based opioid agonists, such as buprenorphine or extended-release naltrexone, are used to treat opioid dependence, although transitioning to a community programme may be more difficult with naltrexone, which is administered only once a month.17 Experiences in Malaysia could prove useful in other countries with high rates of opioid dependence and HIV infection among prison inmates. Future interventions should not, however, focus on MMT as an intervention for exclusive use immediately before a prisoner's release from prison. Instead, MMT should be leveraged throughout the period of incarceration not only to ensure continuity of care for MMT programme participants, but also to ensure adequate MMT dosing before release from prison and avoid the risky injection of opioids within prisons.
Box 1. Summary of main lessons learnt
- Initiation of methadone within prison requires slow, individualized dosing.
- Linking individuals to MMT in the community requires strong relationships between prison- and community-based clinics and improved communication between prison and police authorities.
- Post-release retention on MMT can be hampered by police harassment near MMT sites and forced relocation laws, which are major deterrents to continuity of care and relapse prevention.
This research was supported by research grants from the National Institute on Drug Abuse for research (R01 DA025943, Altice, PI) and a grant from the University of Malaya (HIRGA E000001-20001, Kamarulzaman), as well as a National Institute on Drug Abuse career development award (K24 DA017072, Altice).
Competing interests:
None declared.
- Malaysia country advocacy brief: injecting drug use and HIV. Geneva: Joint United Nations Programme on HIV/AIDS; 2009.
- Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010; 376: 367-87 doi: 10.1016/S0140-6736(10)60829-X pmid: 20650518.
- Hedrich D, Alves P, Farrell M, Stöver H, Møller L, Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 2012; 107: 501-17 doi: 10.1111/j.1360-0443.2011.03676.x pmid: 21955033.
- Merrall EL, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, et al., et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105: 1545-54 doi: 10.1111/j.1360-0443.2010.02990.x pmid: 20579009.
- Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, et al., et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry 2006; 63: 102-9 doi: 10.1001/archpsyc.63.1.102 pmid: 16389204.
- Schwartz RP, Kelly SM, O'Grady KE, Mitchell SG, Peterson JA, Reisinger HS, et al., et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict 2008; 17: 396-401 doi: 10.1080/10550490802268835 pmid: 18770082.
- Dolan KA, Wodak AD, Hall WD. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev 1998; 17: 153-8 doi: 10.1080/09595239800186951 pmid: 16203480.
- Howells C, Allen S, Gupta J, Stillwell G, Marsden J, Farrell M. Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone. Drug Alcohol Depend 2002; 67: 169-76 doi: 10.1016/S0376-8716(02)00024-8 pmid: 12095666.
- Kerr T, Jurgens R. Methadone maintenance therapy in prisons: reviewing the evidence. Montreal: Canadian HIV/AIDS Legal Network; 2004.
- Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O'Grady KE. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat 2009; 37: 277-85 doi: 10.1016/j.jsat.2009.03.002 pmid: 19339140.
- Gorta A. Monitoring the New South Wales methadone program: 1986–1991. New South Wales: Department of Corrective Services; 1992.
- Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS 2010; 21: 416-23 doi: 10.1258/ijsa.2009.009180 pmid: 20606222.
- Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy 2007; 18: 136-40 doi: 10.1016/j.drugpo.2006.12.015 pmid: 17689356.
- Noordin NM, Merican MI, Rahman HA, Lee SS, Ramly R. Substitution treatment in Malaysia. Lancet 2008; 372: 1149-50 doi: 10.1016/S0140-6736(08)61479-8 pmid: 18926274.
- Wickersham JA, Zahari MM, Azar MM, Kamarulzaman A, Altice FL. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend 2013.
- Mohamad N, Bakar NH, Musa N, Talib N, Ismail R. Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy. Harm Reduct J 2010; 7: 30- doi: 10.1186/1477-7517-7-30 pmid: 21167035.
- Springer SA, Azar MM, Altice FL. HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse 2011; 37: 12-21 doi: 10.3109/00952990.2010.540280 pmid: 21171933.


text:
Are you a journalist? A blogger? Do you have any questions? This section is for you!
Please note that no customer complaint will be processed on this press website. You have to contact the customer relations of your country.
I agree that my data is stored in the database*Required fields
I agree that my data is stored in the database
By continuing your browsing on this site, you agree to the use of cookies to offer you adapted services.


text:
The Sect had been set to play last month, but was sidetracked by technical issues, which won't happen again. Below is the original review:
Italian horror is a strange beast. Were I really pressed on the point, I'm not sure I could name a single Italian horror picture apart from Michele Soavi's Cemetery Man (1994) that I'd call good in any normal sense of the word — and even that film isn't the last word in logic or coherence. It is, however, true to its own logic in ways that most Italian horror isn't, but then most Italian horror simply ignores logic. (Its defenders like to call this "dream logic," which is critic-speak for "makes absolutely no sense.") That's not to say that a great deal of Italian horror isn't enjoyable on its own level. It can be stylish and visually striking — and it can also be atmospheric and creepy. On rare occasions — and I'd argue that Soavi's The Sect (1991) is one of them — the atmosphere becomes even more unsettling because of the film's lack of coherence. In terms of the actual architecture in the film — also true of his 1989 film The Church and Soavi's mentor Dario Argento at his best — there is something that might qualify as "dream logic," or, more correctly, "dream illogic." None of this, however, keeps the film from being so supremely screwed up that it doesn't frequently topple over into the unintentionally funny — but that, too, is part of the appeal.
At bottom, The Sect is a kind of acid-trip version of Rosemary's Baby (1969). I mean, for whatever reason, Roman Polanski never thought of adding a possessed, TV-watching rabbit (one that can operate the remote control), an ill-intentioned handkerchief with Shroud of Turin properties, some kind of parasitic creature introduced into the heroine's body, a hokey enraged stork, bikers, a seemingly endless cellar with a weird well that introduces some blue substance into the water supply, stork rape and … well, all sorts of things on about that same level of outright peculiarness. Indeed, whatever else The Sect is, it is admittedly a lot more lively than Rosemary's Baby. I'm not saying that makes it better, but it is a good deal more amusing. What that was Soavi's intention is another concern altogether — and one that has absolutely no bearing on its entertainment value.
The Thursday Horror Picture Show will screen The Sect Thursday, Nov. 7, at 8 p.m. in the Cinema Lounge at The Carolina Asheville and will be hosted by Xpress movie critics Ken Hanke and Justin Souther.


text:
Copyright© 2019, Regional Multiple Listing Service of Minnesota, Inc. All rights reserved. *Sold data is not available on any property until the sale of the property has closed and ownership has transferred. This home sale information is not an appraisal, competitive or comparative market analysis, CMA or home valuation. The data relating to real estate for sale on this site comes in part from the Broker Reciprocity program of the Regional Multiple Listing Service of Minnesota, Inc. Real Estate listings held by brokerage firms other than Edina Realty Inc. are marked with the Broker Reciprocity logo or the Broker Reciprocity house icon and detailed information about them includes the names of the listing brokers. Edina Realty is not a Multiple Listing Service MLS, nor does it offer MLS access. This website is a service of Edina Realty, a broker Participant of the Regional Multiple Listing Service of Minnesota, Inc. Open House information is subject to change without notice.
Information is deemed reliable but is not guaranteed.
For sale: Properties which are available for showings and purchase
Active contingent: Properties which are available for showing but are under contract with another buyer
Pending: Properties which are under contract with a buyer and are no longer available for showings
Sold: Properties on which the sale has closed.
Coming soon: Properties which will be on the market soon and are not available for showings.
Contingent and Pending statuses may not be available for all listings


text:
Kurukshetra Hindi Magazine December 2016 PDF Free Download
Kurukshetra is a monthly magazine published by Govt. of India in Hindi and English.The magazine carries educative and informative articles on rural development and is very useful for aspirants preparing for UPSC exam.
- Yojana Edition : December 2016
- File Type : PDF
- Language : Hindi
- Download Link : Click here to download


text:
Wide-screen LCD monitors of the same dimensions can vary greatly in price and features, which makes comparison shopping a necessary step. For example, the Dell P2210 may be found online for $100 cheaper than the NEC MultiSync EA221WM (the subject of this review), but the NEC offers four-way ergonomic support, including screen height adjustment, 360-degree panel swiveling, pivot, and tilt. Also, it has slightly better movie and gaming performance than the P2210 and includes built-in speakers and a headphone jack. However, the NEC has a fairly large carbon footprint, compared with the P2210, and no HDMI connection. Obviously, the NEC isn't the end-all be-all in this comparison, so if price is a concern, we'd recommend the P2210, which has most of the same features besides the built-in sound. On the other hand, if solid performance in a feature-rich package is what you're after, the NEC will suit you nicely.
Design and features
The 22-inch NEC MultiSync EA221WM is plainly designed, with a black matte finish. The bezel measures a short 0.6-inch on the right and left sides, while the panel is 1.3 inches deep. Once you add in the back of the display, which houses the connection options and ventilation system and extends another 1.4 inches, the full monitor depth comes to about 2.85 inches. (By comparison, most 22-inch models we've tested have a total depth of about 3 inches.) The panel measures 19.8 inches wide, which is average for a monitor of this screen size.
The NEC MultiSync EA221WM also comes with a circular footstand that measures 4.25 inches in diameter and lets you adjust the height of the display by up to 4.35 inches; when adjusted to its lowest, the distance from the bottom of the bezel to the desktop is about 2 inches. At its lowest height, we saw only minimal wobbling when we knocked it from the sides; however, with the panel height extended to its fullest, the wobbling got noticeably more violent. The panel also pivots to the left 90 degrees--useful if you prefer portrait mode--and it swivels 360 degrees and tilts back about 25 degrees. The stand can be removed and the display mounted to the wall, VESA-style, though you'll have to supply your own mount. Also, on the upper back of the panel is a groove that acts as a useful carrying handle.
NEC includes DVI and VGA as connection options on this monitor, and while the VGA cable is easy to access, the DVI is a bit too close to the stand; we found that our knuckles rubbed it whenever connecting the DVI. Unfortunately, there is no HDMI connection, which is a mainstay on most monitors. However, the unit includes four USB downstream ports--two each on the left edge and backside of the panel--as well as one upstream USB connection on the back next to the VGA port. There are also two downward-facing speakers are built into either side of the panel near the bottom, and the left speaker includes a headphone jack on its side. The back of the stand incorporates two easily accessible cable routers.
The onscreen display button array is located on the bottom right of the bezel, just left of the power button, and includes three buttons--Menu, Select, and Reset/DV Mode--and one "joystick" for navigation. Pressing Menu gives you access to controls for brightness, contrast, color temperature, individual RGB adjusting, auto off, and speaker volume. Also, there's an Eco Mode that caps the brightness at 60 percent when turned on. The DV Mode includes five different presets: Standard, Text, Movie, Gaming, and Photo. Switching through these simply adjusts the brightness to be appropriate for the task at hand. The select button lets you switch from DVI to VGA and the Reset/DV mode button acts as a shortcut to the different presets. The small nub-like joystick made navigating the OSD fairly painless. The stick has four directions, letting you cycle through selections with relative ease, although the NEC's OSD is still not as elegant as that of the Dell P2210.
The NEC MultiSync EA221WM's 16:10 aspect ratio has a 1,680x1,050 native resolution. The 16:9 monitor trend currently sweeping the market has given many smaller monitors higher resolutions than they were capable of at 16:10. For example, a 22-incher (or 21.5) with a 16:9 aspect ratio has a potential native resolution of 1,920x1,080 pixels. It's disappointing that NEC did not include 16:9 here because high-definition content--in particular 1080p movies--can fit onto a 1,920x1,080-pixel screen without distorting the image.
Manufacturer's specifications:
Resolution: 1,680x1,050 pixels
Pixel-response rate: 5ms
Contrast ratio: 1,000:1
Brightness: 250cd/m2
Connectivity: DVI, VGA
HDCP compliant? Yes
Included video cables? DVI, VGA
Backlight type: CCFL
Panel type: TN
Aspect Ratio: 16:10
We tested the NEC MultiSync EA221WM with its DVI connection. The display posted a composite score of 91 on CNET Labs' DisplayMate-based performance tests. We compared it with the 22-inch Dell P2210, which scored an 87. Our grayscale tests evaluate a monitor's capability to distinguish dark gray from black as well as its capability to display the every shade of gray between black and white. While the P2210 had trouble distinguishing dark gray from black, the EA221WM had no such problems, getting near perfect scores in our grayscales tests.
In our color ramping tests, which checks for color banding, the EA221WM performed only slightly better than the P2210, suggesting that while both monitors could have color banding issues in certain apps, the NEC is less likely to do so.
The NEC MultiSync EA221WM achieved a brightness score of 241 candelas per square meter (cd/m2)--right in keeping with NEC's claimed 250 cd/m2 max. The Dell P2210 achieved a higher brightness with 259 cd/m2, but missed Dell's claimed 300 cd/m2 by a wider margin. On our dark screen test, both monitors exhibited significant backlight bleed through on the top and bottom edges of the displays.
Our "Kill Bill Vol. 1" DVD ghosting test yielded minimal ghosting on both the NEC and Dell. We played the movie in each monitor's respective "Movie" preset. The NEC's movie preset proved too bright and we preferred using the standard mode since the black level was lower and the colors more full. While the Dell's movie mode displayed the movie well, the colors were not as full and the black level wasn't as low as the NEC in standard mode.


text:
Top Deals for Tuesday, April 1, 2014
1. Buy 3, Get 3 Free
Bath and Body Works. Expires 4/6
2. Save up to 40% Off Dyson DC39 Total Clean Vacuum with Bonus Attachments
The Home Depot. Expires 5/30
3. Get 6% Cash Back on $50 at the Gap, Banana Republic, Old Navy or Athleta. In-store. Expires 4/30
41% off at Banana Republic today only with code BRAPRIL41
35% off GAP with code SAVE. Expires tomorrow 4/2
15% off Old Navy today only with code KICK


text:
Greenville NC Real Estate
South Carolina isn't the only Carolina with a Greenville. There are thousands of Greenville, NC real estate owners who will tell you that their Greenville is the place to be. Settled in 1771, Greenville, North Carolina is the county seat of Pitt County. In 2011, the city was named 10th largest in the state of North Carolina.
Residents of Greenville, NC enjoy their city for a number of reasons. From great healthcare, wonderful business opportunities, and incredible views, Greenville, NC real estate owners are happy to call the metropolis area home.
In June 2012, Forbes Magazine ranked Greenville as one of the top ten "Best Places for Business and Careers" in the nation. Two years earlier, the same magazine ranked Greenville, NC as 24th in mid-city business growth and development.
Perhaps the fact that East Carolina University is the third-largest university in the state, and has the fastest-growing campus in the UNC system attributes to that fact. Then again, Greenville's excellent educational opportunities could have something to do with the fact that Greenville is a popular place for young people to live.
The 20-something demographic is quickly snatching up Greenville real estate. In January of 2008 and in January of 2010, Greenville, North Carolina was ranked one of the country's "100 Best Communities for Young People." The rankings are published annually by the America's Promise Alliance.
Of course, young people aren't the only ones who want to own their share of Greenville real estate. More than 1700 licensed medical providers call Greenville, North Carolina home. Together, these professionals serve more than 1.2 million residents. The Vidant Medical Center, and the East Carolina Heart Institute with its six-floor facility, have brought in professionals and specialists from all over the country and the world.
However, life in Greenville isn't just about education, business, and medicine. While these may be some of the city's strengths, there are many more Greenville residents who are hard at work boosting the city's culture and arts reputation. East Carolina University is appreciated throughout the Greenville, North Carolina metropolis for music, theater, and dance productions. Additionally, the Greenville Museum of Art attracts more than 12,000 people per year.
If you're looking to live in a city that has a thriving economy, the best health care in the state, and plenty of culture, let us help you call Greenville home. We have the most thorough listing of Greenville NC real estate homes for sale that you'll find. For more information about Greenville NC Homes for Sale Get in touch with Aldridge and Southerland Realtors today.
Community Listings
Average List Price: $210,414
Average Days on Market: 131
1776 Blue Banks Farm Road Greenville, NC 27834
Single Family Home
1645 Deep Run Road Greenville, NC 27834
Single Family Home
160 Holly Hills Road Greenville, NC 27858
Single Family Home
3906 Cantata Drive Greenville, NC 27858
Single Family Home
603 White Horse Drive Greenville, NC 27834
Single Family Home
4003 Hidcote Court Greenville, NC 27834
Single Family Home
314 Woodspring Lane Greenville, NC 27834
Single Family Home
231 Orton Drive Greenville, NC 27858
Single Family Home
3908 Fernwood Lane Greenville, NC 27834
Single Family Home
2415 E 5th Street Greenville, NC 27858
Single Family Home
108 Hawthorne Road Greenville, NC 27858
Single Family Home
367 listings found. Showing 12 per page.


text:
No. 98,553
1. K.S.A. 22-3504 only applies if a sentence is illegal. The question of whether a sentence is illegal is a question of law over which this court has unlimited review. An illegal sentence is a sentence imposed by a court without jurisdiction, a sentence which does not conform to the statutory provision, either in character or the term of the punishment authorized, or a sentence which is ambiguous with regard to the time and manner in which it is to be served.
2. Where the relief sought is reversal of a conviction rather than the correction of an illegal sentence, K.S.A. 22-3504 is unavailable as a vehicle to obtain such relief.
Appeal from Miami district court; STEPHEN D. HILL, judge. Opinion filed June 27, 2008. Affirmed.
Todd M. Deal, appellant pro se, was on the brief for appellant.
David L. Miller, County Attorney, and Paul J. Morrison, attorney general, were on the brief for appellee.
The opinion of the court was delivered by
NUSS, J.: Following this court's affirmance of Todd M. Deal's conviction for first-degree murder, he filed a motion for correction of an illegal sentence pursuant to K.S.A. 22-3504(1). The district court denied the motion, and Deal appeals. Because a life sentence was imposed, our jurisdiction is pursuant to K.S.A. 22-3601(b)(1). State v. Thomas, 239 Kan. 457, Syl. ¶ 2, 720 P.2d 1059 (1986) (jurisdiction over appeal of a motion to correct illegal sentence lies with court that had jurisdiction to hear original appeal). We affirm.
Todd M. Deal was convicted by a jury of first-degree murder in 1999 and was sentenced to 25 years in prison. His conviction was affirmed by this court in State v. Deal, 271 Kan. 483, 23 P.3d 840 (2001). He then filed a motion pursuant to K.S.A. 60-1507, claiming ineffective assistance of counsel. The district court denied Deal's claim, and the Court of Appeals affirmed. Deal v. State, No. 92,163, unpublished opinion filed May 6, 2005, rev. denied, 280 Kan. 981 (2005).
On June 30, 2003, Deal filed a pro se motion to correct an illegal sentence. He first argued that the complaint was jurisdictionally defective because it added elements not required by the first-degree murder statute. Specifically, he objected to the inclusion of the words "unlawfully," "feloniously," and "by suffocation, drowning and/or strangulation."
Deal's four remaining arguments were all essentially based upon his claim that the complaint was defective. He argued that the jury instruction defining first-degree murder omitted the complaint's added elements, i.e., "unlawfully," "feloniously," and "by suffocation, drowning, and/or strangulation." He next argued that his trial counsel was ineffective for failing to object to these purported complaint defects and for failing to file a related motion for arrest of judgment. Deal additionally argued that the State presented insufficient evidence to establish one of the complaint's added elements: that the victim died by suffocation, drowning, or strangulation. Finally, he argued that the defective complaint prevented the district court from having jurisdiction to accept a finding of his guilt.
In denying the motion, the district court found that the complaint "was a plain and concise written statement of the essential facts constituting the crime charged following the language of the statute and was legally sufficient." It also rejected Deal's other arguments, holding that they had already been addressed in the rejected 60-1507 motion.
Deal's motion was filed pursuant to K.S.A. 22-3504, which only applies if a sentence is illegal. See State v. Hoge, 283 Kan. 219, 225, 150 P.3d 905 (2007). There, we acknowledged that the question whether a sentence is illegal is a question of law over which this court exercises unlimited review. 283 Kan. at 225. We also acknowledged having previously defined an illegal sentence as "a sentence imposed by a court without jurisdiction, a sentence which does not conform to the statutory provision, either in the character or the term of the punishment authorized, or a sentence which is ambiguous with respect to the time and manner in which it is to be served." 283 Kan. at 225.
Most important, we reiterated in Hoge that a motion to correct an illegal sentence is not the appropriate vehicle by which to bring a claim that the complaint was defective. Hoge, 283 Kan. at 225-26: see State v. Nash, 281 Kan. 600, Syl. ¶ 2, 133 P.3d 836 (2006). The Nash defendant argued that the complaint alleging felony murder and aggravated robbery was fatally defective because he was charged with taking property only from the "presence" of another rather than from the "person or presence" of another. (Emphasis added.) 281 Kan. at 601. The Nash court rejected the defendant's motion to correct an illegal sentence because it effectively was a collateral attack on his conviction, not one seeking "correction of the sentence imposed on the conviction." 281 Kan. at 602.
The Hoge defendant made arguments similar to the ones brought by Deal in the present case. Hoge argued:
"[T]he complaint and accompanying jury instruction were 'jurisdictionally and fatally defective.' According to Hoge, his due process rights were violated because certain language in the complaint and jury instruction was not identical to the applicable statutory language. He contended that the first-degree murder charge erroneously included the terms 'unlawfully,' 'by shooting,' and 'inflicting injuries' and that this language was then erroneously omitted from the accompanying jury instruction." (Emphasis added.) 283 Kan. at 220.
The Hoge court rejected its defendant's motion based upon a defective complaint for the same reason given in Nash. Both opinions' results and rationale control here. Simply put, Deal does not attack his sentence: he merely challenges his conviction. That challenge would more properly be brought in a motion under K.S.A. 60-1507. But see State v. Breedlove, 285 Kan. 1006, 179 P.3d 1115 (2008) (defendant challenged sentence under K.S.A. 22-3504, seeking to have his sentence vacated, but conviction overturned because district court did not have jurisdiction to try him as juvenile).
Here, as the district courts also should have done in Nash and Hoge, the district court should have denied relief on the basis that the only relief sought was not available under the statute. However, where the district court reaches the right result, albeit for the wrong reason, it will not be reversed. Nash, 281 Kan. at 602.


text:
Support and Information
The impact of sexual trauma often extends long after the initial shock of the event. While some patterns can be observed as general reactions to sexual trauma, each survivor's individual experience and needs in the aftermath of trauma are unique. Often survivors report that it's challenging to process what has happened and place the event within the context of their lives. As a survivor interacts with her environment, she may find herself in situations that remind her of the traumatic event that may bring up an array of thoughts and feelings or even somatic experiences such as heart racing, palms sweating or feeling pain in the body. Please know that these are all natural, expected reactions as an individual recovers from trauma. Resources and support are available so that this journey toward healing does not need to happen in isolation.
This following are resources that may be helpful:
In an emergency situation, always call 911. Emergency situations include a recent threat of violence, recent act of violence or if someone's health is in imminent danger.
Crisis Hotlines
All are 24 hours a day unless otherwise noted
- Rape, Abuse and Incest National Hotline
1-800-656-HOPE | www.rainn.org
Online Hotline: online.rainn.org
En español: rainn.org/es
- Planned Parenthood
1-800-230-7526 | www.plannedparenthood.org
En español: plannedparenthood.org/esp
- National Domestic Violence Hotline
1-800-799-SAFE (7233) or 1-800-787-3224 | www.thehotline.org
Online Hotline: thehotline.org/help/help-for-survivors (click the "Chat Now" button)
En español: espanol.thehotline.org